We assessed α-SMA and ß-catenin level changes in BALF samples and compared them to clinical data (including APACHE II and pulmonary infection scores) to explore the association between the expression of α-SMA and ß-catenin levels and the severity of pneumonia to provide guidance for patient management and prognoses. This evidence concerns the gene ACTA1 and pneumonia.